Ionis to license hep B programme to GSK PharmaTimes
GSK is now responsible for all development, regulatory and commercialisation activities and costs. – News – PharmaTimes.
(Visited 2 times, 1 visits today)
Fighting Cancer!
-
A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips (4)
A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips Most of us thrive on routine and a sense of normality in our lives. This…
Read more -
Simple Ways To Manage Cancer (3)
Simple Ways To Manage Cancer There are millions of cases of cancer diagnosed around the world every year. Some are severe and others are definitely curable, but they will all…
Read more -
Cancer: Advice On Learning How To Cope (2)
Cancer: Advice On Learning How To Cope If you or a loved one has been diagnosed with cancer, it can be a very scary time. There are so many questions…
Read more -
What To Look For When Choosing An Oncologist (2)
What To Look For When Choosing An Oncologist Many of us never actually stop to smell the proverbial roses until we find out that we don’t have a lot of…
Read more -
Tips On How To Steer Away From Cancer (5)
Tips On How To Steer Away From Cancer Being able to have a friendly and informative back-and-forth conversation with your doctor is crucial if you want to know your treatment…
Read more